The results showed that FKN treatment could ameliorate microglia activation via inhibiting NF‐κB pathway and enhancing Nrf2 pathway, thus to reduce the production of inflammation‐related cytokines and ROS, and protect the retina from diabetes insult. Here, CX3CL1 is linked to diabetes mellitus.